SEARCH UNITED STATES ABOUT RESEARCH & DEVELOPMENT RESPONSIBILITY Home Page About Compliance Vermont Prescriber Information VERMONT PRESCRIBER INFORMATION Idhifa Short Form Long Form Inrebic Short Form Long Form Pomalyst Short Form Long Form Revlimid Short Form Long Form Thalomid Short Form Long Form Information for Vermont Prescribers of Prescription Drugs Notice to Vermont Prescribers The Vermont “Pharmaceutical Marketer Price Disclosure Law” requires pharmaceutical marketers to disclose to Vermont doctors and other prescribers the prices of drugs they market as well as the prices of other drugs in the same therapeutic class. This information for Celgene Corporation products is provided below. Price Information The prices listed below are Average Wholesale Prices (AWP) as established and made available to the public by a third party publisher, or as calculated from data made available to the public by a third party publisher. Information about AWP of these drugs is being provided to Vermont prescribers pursuant to Vermont law, to give you information about the relative prices of marketed drugs and other drugs in the same therapeutic class. The price paid by consumers may be higher or lower than the prices listed below. The prices listed do not necessarily reflect price per dosage, price per course of treatment, or the cost effectiveness of all the products listed. For simplicity, only the smallest package sizes available for each product are included. Notices/Disclaimers The various statements that appear on the disclosure forms are required under the Vermont Attorney General’s Guide to Pharmaceutical Marketer Price Disclosure Law (“AG Guide”). The statements are reproduced by us without alteration. “Other Products” The “Other Products” identified on the forms are the other products listed in the same class as the marketed product in the 2004 American Hospital Formulary System (“AHFS”) Pharmacologic-Therapeutic Classification system. The AG Guide requires manufacturers to use the AHFS classification system. The listing of other products in the forms does not imply that such other products are interchangeable with the marketed product or have the same safety or efficacy. Please refer to each product’s FDA-approved label and indication for further information. More Information For more information on the price disclosure requirements, please contact the Attorney General’s office: Office of the Attorney General 109 State Street Montpelier, VT 05609-1001 Ph. (802) 828-3171 Fx. (802) 828-5341 aginfo@atg.state.vt.us The AG Guide and other information on the Price Disclosure Law are also available on the Attorney General’s web site and can be accessed at www.atg.state.vt.us. Font Size About Compliance Vermont Prescriber Information Celgene History Global Office Locations GLOBAL OFFICE LOCATIONS HAVE A QUESTION OR CONCERN? CONTACT US ABOUT RESEARCH & DEVELOPMENT RESPONSIBILITY INVESTORS SITE MAP PRIVACY POLICY LEGAL NOTICE COPYRIGHT © 2021 CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY PRIVACY POLICY LEGAL NOTICE Celgene is a Bristol-Myers Squibb company Select CONTINUE for information about Celgene. Select BMS to learn more about Bristol Myers Squibb. CONTINUE BMS